D levels. 4 Therefore, we hypothesize that patients with BCC have higher vitamin D levels, which may protect against severe COVID-19 outcomes. While serum 25-hydroxyvitamin D has been positively associated with melanoma and keratinocyte carcinoma, particularly BCC, 5,6 there may be other residual confounders in patients with COVID-19 with SCC and melanoma that were impossible to elucidate from the data, such as duration of immunosuppression, severity of chronic skin inflammation and genetic make-up, which could have contributed to the findings of the given outcomes. A limitation of this study is that because vitamin D levels are not routinely assessed in either in-or outpatients, there were incomplete records of vitamin D levels in the database and so pre-existing levels could not be examined. Other limitations include possible errors in coding/data entry, a bias towards sicker patients and the inability to monitor progression through the clinical course of the disease. Further studies are warranted in patients with skin cancer to validate this finding.